Role of MRP-1 and GST-Pi in MDR and their inhibition by indomethacin in AMLFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 16 August 2016

References

• E.L.NieroB.Rocha-SalesC.LauandB.A.CortezM.M.de SouzaP.Rezende-TeixeiraThe multiple facets of drug resistance: one history, different approachesJ Exp Clin Cancer Res33201437
   PubMed Web of Science ®Google Scholar
• S.P.ColeTargeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and futureAnnu Rev Pharmacol Toxicol54201495117
   PubMed Web of Science ®Google Scholar
• J.P.GilletM.M.GottesmanMechanisms of multidrug resistance in cancerMethods Mol Biol59620104776
   PubMedGoogle Scholar
• S.SinghCytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell deathCancer Chemother Pharmacol752015115
   PubMed Web of Science ®Google Scholar
• R.O’ConnorThe pharmacology of cancer resistanceAnticancer Res200712671272
   Google Scholar
• YC1GuoC.M.ChangW.L.HsuS.J.ChiuY.T.TsaiY.H.ChouIndomethacin inhibits cancer cell migration via attenuation of cellular calcium mobilizationMolecules18201365846596
   PubMed Web of Science ®Google Scholar
• F.A.NichollsJ.T.AhokasInhibition of purified glutathione S-transferases by indomethacinBiochem Biophys Res Commun119198410341038
   PubMed Web of Science ®Google Scholar
• D.J.A.de GrootM.van der DeenT.K.P.LeA.RegelingS.de JongE.G.E.de VriesIndomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1Br J Cancer97200710771083
   PubMed Web of Science ®Google Scholar
• J.H.WeisburgMultidrug resistance in acute myeloid leukemia: potential new therapeuticsJ Nucl Med49200814051407
   Web of Science ®Google Scholar
• P.G.BoardD.MenonGlutathione transferases, regulators of cellular metabolism and physiologyBiochim Biophys Acta1830201332673288
   PubMed Web of Science ®Google Scholar
• B.T.HuangZ.XiaoY.T.ShiS.HaW.H.ZhaoD.GaoExpressions of LRP, GST-pi and MRP1 in acute leukemia patients and its clinical significanceZhongguo Shi Yan Xue Ye Xue Za Zhi152007262266
   Google Scholar
• A.LohriB.V.HilleM.BacchiM.FoppF.JoncourtJ.ReuterFive putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIα) in 57 newly diagnosed acute myeloid leukaemiasEur J Haematol592009206215
   Google Scholar
• S.GalimbertiR.TestiF.GuerriniR.FazziM.PetriniThe clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemiaJ Chemother12003374379
   Web of Science ®Google Scholar
• H.ShiD.LuY.ShuW.ShiS.LuK.WangExpression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinomaCancer Invest262008344351
   PubMed Web of Science ®Google Scholar
• V.J.FindlayD.M.TownsendK.D.TewGlutathione and Glutathione S-Transferases in drug resistanceB.A.TeicherCancer drug resistance2006Humana Press Inc.New Jersey (USA)213222
   Google Scholar
• A.De LucaL.FedericiM.De CanioL.StellaA.M.CaccuriNew insights into the mechanism of JNK1 inhibition by glutathione transferase P1-1Biochemistry51201273047312
   PubMed Web of Science ®Google Scholar
• L.GilbertL.J.ElwoodM.MerinoS.MasoodR.BarnesA pilot study of the pi class Glutathione-S-Transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancerJ Clin Oncol1119934958
   PubMed Web of Science ®Google Scholar
• G.A.AltenbergStructure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamillyCurr Med Chem Anticancer Agents420045362
   PubMedGoogle Scholar
• M.FilipitsR.W.SuchomelS.ZöchbauerR.BrunnerK.LechnerR.PirkerMultidrug resistance-associated protein in acute myeloid leukemia: no impact on treatment outcomeClin Cancer Res3199714191425
   PubMed Web of Science ®Google Scholar
• M.FilipitsT.StranzlG.PohlH.HeinzlU.JagerK.GeisslerDrug resistance factors in acute myeloid leukemia: a comparative analysisLeukemia1420006876
   PubMed Web of Science ®Google Scholar
• F.MahjoubiM.GolalipourA.GhavamzadehK.AlimoghaddamExpression of MRP1 gene in acute leukemiaSao Paulo Med J1262008172179
   PubMed Web of Science ®Google Scholar
• D.M.Van der KolkE.G.de VriesL.NoordhoekActivity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemiaLeukemia15200115441553
   PubMed Web of Science ®Google Scholar
• M.SchaichS.SoucekC.ThiedeG.EhningerT.IllmerSHG AML96 Study Group: MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemiaBr J Haematol1282005324332
   PubMed Web of Science ®Google Scholar
• J.H.DoS.H.OhE.J.SongJ.S.ChungC.D.KangE.Y.LeeTreatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemiaKorean J Lab Med272007229236
   Google Scholar
• L.Moureau-ZabottoS.RicciJ.P.LefrancF.CouletC.GenestieM.AntoinePrognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patientsBr J Cancer942006473480
   PubMed Web of Science ®Google Scholar
• E.TurriniL.FerruzziC.FimognariNatural compounds to overcome cancer chemoresistance: toxicological and clinical issuesExpert Opin Drug Metab Toxicol10201416771690
   PubMed Web of Science ®Google Scholar
• J.H.SongS.H.KimH.-J.KimS.Y.HwangT.S.Sung KimAlleviation of the drug-resistant phenotype in idarubicin and cytosine arabinoside double-resistant acute myeloid leukemia cells by indomethacinInt J Oncol322008931936
   Web of Science ®Google Scholar
• M.P.DraperR.L.MartellS.B.LevyIndomethacin mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoproteinBr J Cancer751997810815
   PubMed Web of Science ®Google Scholar
• S.MatsunagaT.AsanoA.Tsutsuda-AsanoY.FukunagaIndomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1)Cancer Chemother Pharmacol582006348353
   PubMed Web of Science ®Google Scholar